B2K906 AF NFT

Glucokinase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiddxp5wz47pdzjg65tssdnir3dch43d4s4vvydfc2lrjqs3ceuvpy/metadata.json
IPFS of structure file: 
bafybeicnwuqvsqjn4o4efme3dasvy5hwilsn5mmnlzxt5n7c7x7dawksge/AF-B2K906-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x627DfEbfC08CCF86E151D6C3143e17Eada033427
First NFT owner address (bech32): 
genesis1vf7la07q3n8cdc236mp3g0shatdqxdp8kmnu87
Current NFT ID #149288 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
149288
Accession (UniProt):
B2K906
Name::
Glucokinase
Experimental Method:
Predicted structure
Sequence source:
Yersinia pseudotuberculosis serotype IB (strain PB1/+)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2K906 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2K906|GLK_YERPB Glucokinase OS=Yersinia pseudotuberculosis serotype IB (strain PB1/+) OX=502801 GN=glk PE=3 SV=1 MTTYALVGDVGGTNARLALCAVATGEILQAKTYSGLEYESLEDVIKQYLSEHQAKVTDACIAIACPITGDWVAMTNHTWAFSIAAMQQNLGLDHLEVINDFTAVSMAIPVLPAQDVLQFGGTQPQPGKPVAVYGAGTGLGVAHLVNVDRRWISLAGEGGHVDFAPNSEEEDQILAVLRQELGHVSAERVLSGPGLVNLYRAIVISDARLPEKLAPKDITARALADSCTDCRRALSLFCVIMGRFGGNLALNLSTFGGVYIAGGIVPRFMEFFKASGFRAAFEDKGRFKDFLQDIPVYMITHPQPGLLGAGAYLRQKLGYELSS